Oxazolyl-pyrazole derivatives as kinase inhibitors
US7105535B2 · kind B2 · utility
26Cited by
0References
27Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 28, 2002 |
| Grant date | Sep 12, 2006 |
| Priority date | — |
| Expiry date | Oct 3, 2022 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D413/14
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compounds which are oxazolyl-pyrazole derivatives, as defined in the specification, and pharmaceutically acceptable salts thereof; are useful in the treatment of diseases caused by and/or associated with an altered protein kinase activity such as cancer, cell proliferative disorders, viral infections, autoimmune diseases and neurodegenerative disorders.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.